Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

NCT04318678 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.

NCT NCT04318678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04318678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
Lead sponsor
St. Jude Children's Research Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
July 29, 2020
Completion date
July 29, 2030
Enrollment
108 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aml/mds, b-all, bpdcn, t-all